Bumper Offer - Urjas oil Just @ Rs. 1
Ramipres H 2.5mg/12.5mg Tablet is a prescription medicine that is available as a Tablet. The alternative uses of Ramipres H 2.5mg/12.5mg Tablet have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Ramipres H 2.5mg/12.5mg Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
The most common side effects of Ramipres H 2.5mg/12.5mg Tablet are Confusion. While these are the most often observed Ramipres H 2.5mg/12.5mg Tablet side effects, there are can be others also. These have been listed below. Usually, these side effects of Ramipres H 2.5mg/12.5mg Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Ramipres H 2.5mg/12.5mg Tablet has a Safe effect for pregnant women and Safe effect on lactating mothers. Warnings related to Ramipres H 2.5mg/12.5mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Ramipres H 2.5mg/12.5mg Tablet is contraindicated in people with pre-existing medical conditions like Angioedema, Heart Failure, Low Blood Pressure (Hypotension) as it can result in adverse effects. Other conditions have been mentioned below in the Ramipres H 2.5mg/12.5mg Tablet contraindications section.
Drug reaction of Ramipres H 2.5mg/12.5mg Tablet with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Ramipres H 2.5mg/12.5mg Tablet is considered not safe while driving, and is not addictive.
Ramipres H 2.5mg/12.5mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Ramipres H 2.5mg/12.5mg Tablet is used -
Moderate
Mild
Common
Is the use of Ramipres H 2.5mg/12.5mg Tablet safe for pregnant women?
Pregnant women can take Ramipres H without worrying about any side effects.
Is the use of Ramipres H 2.5mg/12.5mg Tablet safe during breastfeeding?
Breastfeeding women can safely use Ramipres H.
What is the effect of Ramipres H 2.5mg/12.5mg Tablet on the Kidneys?
Ramipres H has very mild side effects on the kidneys.
What is the effect of Ramipres H 2.5mg/12.5mg Tablet on the Liver?
Ramipres H has very mild side effects on the liver.
What is the effect of Ramipres H 2.5mg/12.5mg Tablet on the Heart?
Ramipres H has very mild side effects on the heart.
Ramipres H 2.5mg/12.5mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ramipres H 2.5mg/12.5mg Tablet unless your doctor advises you to do so -
Is this Ramipres H 2.5mg/12.5mg Tablet habit forming or addictive?
No, there is no any evidence that Ramipres H 2.5mg/12.5mg Tablet is addictive.
Interaction between Food and Ramipres H 2.5mg/12.5mg Tablet
Some foods when eaten with Ramipres H 2.5mg/12.5mg Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Ramipres H 2.5mg/12.5mg Tablet
Consult your doctor before consuming alcohol while taking Ramipres H 2.5mg/12.5mg Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
